Kieran Gallahue, Chief Executive Officer at RESMED INC (RMD), sold 15,000 shares at $58.87 ($882K) on 2010-03-05, disclosed to the SEC on 2010-03-09.
Scheduled sale ($882k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $58.79 | 10,000 | $588K | 66.6% |
| 2 | $58.87 | 5,000 | $294K | 33.4% |
| Total | $58.82 avg | 15,000 | $882K | 100% |
| Filing → |
| EW | BUY | 2017-02-06 | $270K | — | Filing → |
| EW | BUY | 2016-12-01 | $254K | — | Filing → |
| XENT | BUY | 2016-05-17 | $101K | — | Filing → |